Mesothelioma Immunotherapy Clinical Trial Ends Abruptly – Asbestos.com
Asbestos.com |
Mesothelioma Immunotherapy Clinical Trial Ends Abruptly
Asbestos.com A leading biopharmaceutical company has halted a once-promising mesothelioma clinical trial involving CRS-207 — a listeria-based cancer vaccine — citing efficacy and financial concerns. The phase II trial was designed to test the effectiveness and … |
